OACC

Oaktree Acquisition Corp III Life Sciences
OACC

51 hedge funds and large institutions have $179M invested in Oaktree Acquisition Corp III Life Sciences in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

more capital invested

Capital invested by funds: $ → $

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

27% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 11

Holders
51
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$10.6M
2
+$3.48M
3
+$868K
4
RC
Rangeley Capital
Connecticut
+$225K
5
Citadel Advisors
Citadel Advisors
Florida
+$109K

Top Sellers

1
-$7.12M
2
-$1.9M
3
-$1.24M
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$1.06M
5
Millennium Management
Millennium Management
New York
-$1.05M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
51
Morgan Stanley
New York
$794
DCM
52
Driehaus Capital Management
Illinois
–
CC
53
Centiva Capital
New York
–
1 2
3